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Acute Myocardial Infarction* 
CHARLES E. RACKLEY, MD, FACC 
Washington, D.C. 
The present study. The report by Simoons et al. (1) in this 
issue of the Journal on the long-term benefits of early 
thrombolytic therapy in acute myocardial infarction presents 
several important achievements in this therapeutic area of 
coronary artery disease: 1) Five year survival is increased in 
patients randomized to intracoronary streptokinase com- 
pared with patients receiving conventional therapy; 2) long- 
term survival is related to left ventricular function and 
coronary anatomy at the time of initial follow-up study; and 
3) the greatest improvement in survival is observed in 
patients with anterior infarction, heart failure on admission, 
previous infarction or extensive myocardial ischemia on 
admission. Thus, this study extends the reassuring benefits 
of thrombolytic therapy in acute myocardial infarction be- 
yond the initial hospitalization and the l-year follow-up 
periods. However, it reports several unsettling observations 
over the 5 year period: 1) The reinfarction rate within 3 years 
was more frequent in the recipients of thrombolytic therapy; 
2) bypass surgery and angioplasty were performed more 
frequently in the patients receiving thrombolytic therapy 
than in those treated conventionally; and 3) the frequency of 
myocardial infarction was similar in patients with and with- 
out signs of ischemia on exercise testing. 
Identifying patients at long-term ischemic risk. Thus, this 
long-term study on the benefits of thrombolytic therapy 
raises an important question as to the optimal method for 
identifying patients at long-term ischemic risk. The Throm- 
bolysis in Myocardial Infarction (TIMI) Phase II trial (2) 
suggested that coronary arteriography be performed only in 
those patients developing angina or exhibiting a positive, 
modified exercise test immediately after thrombolytic ther- 
apy. However, the study of Simoons et al. indicates that 
ischemic responses to exercise may not sufficiently identify 
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those patients at future risk for myocardial infarction. Cor- 
onary arteriography in the current study suggested that those 
patients with inferior infarction and those with a >90% 
lesion in the infarct-related vessel are at increased risk for 
future myocardial infarction. A previous study by Little et 
al. (3) demonstrated that a coronary arteriogram obtained 
before subsequent myocardial infarction was not useful in 
predicting the angiographic site of infarction because >60% 
of the patients had a progressive or newly developed lesion 
responsible for the coronary occlusion. Finally, the pharma- 
cologic approach to patients at long-term ischemic risk 
remains an issue, as shown in the current study (l), in which 
only 20% of the patients were taking a beta-adrenergic 
blocker at the end of the 1 year follow-up period and aspirin 
was not routinely administered. 
Interestingly, in the study of Simoons et al. (l), angio- 
plasty during the acute infarction was beneficial, and me- 
chanical revascularization was heavily utilized in the first 3 
years after successful thrombolysis. Nevertheless, this study 
should stimulate cardiologists to search further for means to 
identify the patient at risk for long-term ischemia after 
successful thrombolysis. Perhaps the time has arrived to 
translate risk characteristics such as hypertension, smoking, 
cholesterol level and family history into true risk factors 
such as coronary artery vasomotor tone, endothelial func- 
tion, lipid profiles and platelet function (4-9). Although the 
TIM1 Phase II trial recommended cautious use of coronary 
arteriography in patients after thrombolysis, a number of 
these patients will undergo catheterization to delineate cor- 
onary anatomy and ventricular function (10). In the future, 
measurements at the time of coronary arteriography of 
coronary vascular reactivity, lipid profiles and platelet func- 
tion may enhance the identity of high risk patients (11-14). If 
such coronary vascular profiles identify individuals at long- 
term ischemic risk, then more vigorous therapeutic efforts 
can be undertaken for their future management. Currently, 
symptoms of myocardial ischemia, as well as a positive 
exercise test, best identify lesions with >70% stenosis; in the 
future, the focus may be on recognizing lesions at risk for 
accelerated growth, labile vascular reactivity and platelet 
aggregation (1.5). 
Implications of the study. Thus, the impressive long-term 
study of Simoons et al. (1) not only documents the significant 
achievements of successful thrombolysis and the long-term 
benefits after acute myocardial infarction, but also presents 
future challenges in identifying patients at risk for long-term 
ischemic events. The opportunity is at hand to apply molec- 
ular mechanisms to clinical coronary artery disease. Even 
though such studies as those of Simoons et al. will require 
further confirmation, cardiologists cannot continue their 
current methods of recognition and treatment of myocardial 
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&hernia indefinitely. In the area of coronary artery disease, 
patient numbers are large and health costs are enormous, but 
reruns will simply not satisfy the audience. 
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